$ABIO Recent Headlines After-hours trades still risky,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$ABIO Recent Headlines

After-hours trades still risky, a decade later 2:23 p.m. June 9, 2011 - Kate Gibson
Monday's biggest gaining and declining stocks 3:20 p.m. May 17, 2010 - MarketWatch
MDRNA, ARCA move on patent office updates 1:08 p.m. March 29, 2010 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 3:36 p.m. March 26, 2010 - MarketWatch
ARCA Bio surges 226% on patent 2:22 p.m. March 26, 2010 - Shawn Langlois
ARCA Biopharma shares surge 220% to $8.56 2:02 p.m. March 26, 2010 - Laura Mandaro
Monday's biggest gaining and declining stocks 3:43 p.m. June 1, 2009 - MarketWatch

Arca TF inhibitor an Orphan Drug for hemorrhagic fever 10:14 a.m. Today - Seeking Alpha
ARCA's CFO leaving; COO appointed 6:11 p.m. Dec. 1, 2014 - Seeking Alpha
10-Q: ARCA BIOPHARMA, INC. 5:16 p.m. Nov. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: ARCA BIOPHARMA, INC. 7:14 a.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
ARCA Biopharma: An Undervalued Biotech With A Bright Future 9:50 a.m. July 3, 2014 - Seeking Alpha
Checking In On ARCA Biopharma 7:50 a.m. March 25, 2014 - Seeking Alpha
10-K: ARCA BIOPHARMA, INC. 4:00 p.m. March 20, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notes From One-On-One Meetings During San Fran Biotech Week - Day 2 9:05 a.m. Jan. 23, 2014 - Seeking Alpha
Why Arca Biopharma Is A Buy 2:50 p.m. Jan. 14, 2014 - Seeking Alpha
Arca Biopharma: A Genetically Targeted Drug For Atrial Fibrillation In Heart Failure Patients 3:53 p.m. Jan. 10, 2014 - Seeking Alpha
FDA accepts test to be used in ARCA Biopharma trial 9:16 a.m. Jan. 8, 2014 - Seeking Alpha
FDA Clears ARCA Bio To Start Landmark Personalized Medicine Clinical Trial 10:10 a.m. Dec. 4, 2013 - Seeking Alpha
OCLS – Why Oculus Jumped Over 145% Today 8:27 a.m. Dec. 4, 2013 - InvestorPlace.com
10-Q: ARCA BIOPHARMA, INC. 4:41 p.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Refined And Ready To Rebound: We Like What We See At Arca Bio 8:00 a.m. Sept. 9, 2013 - Seeking Alpha
Arca Biopharma Prepares For A Second Life 4:52 p.m. Aug. 21, 2013 - Seeking Alpha
10-Q: ARCA BIOPHARMA, INC. 4:25 p.m. May 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Market Close: Big Winners & Losers for April 23, 2013 2:51 p.m. April 23, 2013 - 247WallSt.com
Biogen Idec, Celgene And AbbVie Move To New Highs 4:24 p.m. April 22, 2013 - Investors Business Daily
Market Close: Big Winners & Losers for April 22, 2013 2:58 p.m. April 22, 2013 - 247WallSt.com


ARCA biopharma Receives FDA Orphan Drug Designation for rNAPc2 as a Potential Treatment for Ebola 8:31 a.m. Today - BusinessWire - BZX
ARCA biopharma Announces Management Transitions 5:00 p.m. Dec. 1, 2014 - BusinessWire - BZX
LabCorp/ARCA biopharma GENETIC-AF Poster Presented at the 18th Annual Scientific Meeting of the Heart Failure Society of America 7:03 a.m. Sept. 16, 2014 - BusinessWire - BZX
LabCorp/ARCA biopharma GENETIC-AF Poster Selected for Presentation at the 18th Annual Scientific Meeting of the Heart Failure Society of America 7:31 a.m. Sept. 8, 2014 - BusinessWire - BZX
ARCA biopharma Announces Health Canada Acceptance of Genetic-AF Clinical Trial Application 7:31 a.m. Aug. 18, 2014 - BusinessWire - BZX
Robert E. Conway Elected Chairman of ARCA biopharma Board of Directors 7:31 a.m. June 9, 2014 - BusinessWire - BZX
ARCA biopharma to Present at the Growth Capital Expo 2014 8:02 a.m. April 22, 2014 - BusinessWire - BZX
ARCA biopharma Announces Screening of First Patient in Phase 2B/3 Clinical Trial Evaluating Gencaro in Atrial Fibrillation 7:31 a.m. April 17, 2014 - BusinessWire - BZX
ARCA biopharma Files Shelf Registration Statement 3:06 p.m. April 4, 2014 - BusinessWire - BZX
ARCA biopharma CEO Michael R. Bristow to Be Interviewed Live Today on Clear Channel Business Talk Radio 6:05 a.m. March 19, 2014 - Marketwire
Top Gainers Technical Data: Ocean Power Technologies, ARCA Biopharma, Ubiquiti Networks, and Pinnacle Entertainment 8:24 a.m. March 12, 2014 - PR Newswire - PRF
Dan Mitchell Joins ARCA biopharma Board of Directors 9:16 a.m. Feb. 12, 2014 - BusinessWire - BZX
ARCA biopharma Announces Pricing of $9 Million Public Offering of Common Stock and Warrants 8:31 a.m. Feb. 4, 2014 - BusinessWire - BZX
ARCA biopharma Announces Proposed Public Offering of Common Stock and Warrants 4:06 p.m. Feb. 3, 2014 - BusinessWire - BZX
Stock Price Movements, FDA Applications, Appointments, and Clinical Study Updates - Research Report on Alere, ARCA, Achillion, Idenix Pharmaceuticals, and Receptos 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
ARCA biopharma Announces US FDA Acceptance of Gencaro Companion Diagnostic Test IDE 8:30 a.m. Jan. 8, 2014 - BusinessWire
ARCA biopharma to Present at Biotech Showcase 2014 8:30 a.m. Jan. 7, 2014 - BusinessWire
Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma 8:00 a.m. Dec. 9, 2013 - PR Newswire
Stocks Outperformed the Broader Markets: Facebook Inc, Twitter Inc, CF Industries Holdings, Green Mountain Coffee Roasters, Arca Biopharma 9:18 a.m. Dec. 5, 2013 - PR Newswire
ARCA biopharma Announces IDE Submission to US FDA for Gencaro Companion Diagnostic Test 8:30 a.m. Dec. 5, 2013 - BusinessWire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 3

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 4

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights Into December's Top Mobile and CTV Apps for Revenue

Updated Category News Views 170

Top Revenue Generating Mobile and CTV Apps for December 2024 The evolving landscape of mobile and Connected TV (CTV) applications continually captivates users and advertisers alike. As 2024 comes to a close, the spotlight shines on the highest-grossing apps in North America, specifically in the United States and Canada, revealing significant trends in user engagement and...

Continue Reading
LET Mining's Cloud Strategy for XRP: Earn Passive Income Today

Updated Category News Views 106

Introduction to LET Mining's New Approach LET Mining is making waves with its innovative strategy that leverages XRP for cloud mining. This fresh perspective has caught the attention of numerous XRP holders, sparking excitement about its long-term profit potential. As more users join the platform, LET Mining is focusing on refining its computing power allocation to...

Continue Reading
Understanding Recent Changes in American Intl Gr's Short Interest

Updated Category News Views 70

Understanding American Intl Gr's Short Interest Dynamics American Intl Gr (AIG) has recently seen a notable change in its short percent of float, which has decreased by 3.24% since the last report. This change reflects a current total of 10.23 million shares sold short, making up approximately 1.79% of all available shares for trading. With the current trading volume,...

Continue Reading
Exploring the Future of the Phosphate Market: Growth and Trends

Updated Category News Views 520

The Rising Phosphate Market: An Overview The phosphate market is experiencing remarkable growth, projected to soar to approximately $219.74 billion in the coming years, driven by an annual growth rate of 3.9%. This growth is closely linked to the rising global demand for agricultural fertilizers, which play a crucial role in providing essential nutrients for plants....

Continue Reading
Clene Inc. to Engage with Investors at Benchmark Conference

Updated Category News Views 108

Clene Inc. to Engage with Investors at Benchmark Conference Clene Inc. (Nasdaq: CLNN), a dynamic clinical-stage biopharmaceutical company, is making its mark in the healthcare industry by focusing on innovative solutions for neurodegenerative diseases. Their mission is clear: to enhance mitochondrial health and safeguard neuronal functions. With a commitment to tackling...

Continue Reading